Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.34% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHCR
3226
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $111K | ﹤0.01% |
+118,100
| New | +$141K |
|
3227
Key Tronic
KTCC
$44.2M
| $110K | ﹤0.01% |
24,595
-465
| -2% | -$2.38K |
|
3228
Boxlight
BOXL
$2.05M
| $108K | ﹤0.01% |
315
+24
| +8% | +$9.37K |
|
|
CMLS
3229
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $108K | ﹤0.01% |
21,300
+600
| +3% | +$2.85K |
|
|
TRVN
3230
DELISTED
Trevena, Inc.
TRVN
| $107K | ﹤0.01% |
7,098
-188
| -3% | -$4.07K |
|
|
YARW
3231
Yarrow Bioscience, Inc. Common Stock
YARW
$25.2M
| $105K | ﹤0.01% |
520
-202
| -28% | -$44.1K |
|
|
DGXX
3232
Digi Power X Inc
DGXX
$370M
| $105K | ﹤0.01% |
99,499
+72,399
| +267% | +$107K |
|
3233
Direct Digital Holdings
DRCT
$2.05M
| $104K | ﹤0.01% |
185
-145
| -44% | -$81K |
|
|
EAR
3234
DELISTED
Eargo, Inc. Common Stock
EAR
| $104K | ﹤0.01% |
47,980
+1,500
| +3% | +$5.01K |
|
3235
Asia Pacific Wire & Cable
APWC
$66.4M
| $102K | ﹤0.01% |
73,000
+300
| +0.4% | +$523 |
|
3236
NanoViricides
NNVC
$36.5M
| $102K | ﹤0.01% |
76,100
-2,500
| -3% | -$3.54K |
|
3237
SIGA Technologies
SIGA
$226M
| $102K | ﹤0.01% |
19,400
-36,736
| -65% | -$181K |
|
|
ORKA
3238
Oruka Therapeutics
ORKA
$5.86B
| $102K | ﹤0.01% |
4,233
+525
| +14% | +$12.9K |
|
3239
Perspective Therapeutics
CATX
$335M
| $101K | ﹤0.01% |
36,765
-6,928
| -16% | -$32.3K |
|
|
KORE
3240
DELISTED
KORE Group Holdings
KORE
| $101K | ﹤0.01% |
33,259
+2,199
| +7% | +$10.3K |
|
|
OPTN
3241
DELISTED
OptiNose
OPTN
| $101K | ﹤0.01% |
5,487
-3,333
| -38% | -$60K |
|
3242
Telecom Argentina
TEO
$5.93B
| $101K | ﹤0.01% |
+21,121
| New | +$120K |
|
3243
The Oncology Institute
TOI
$513M
| $101K | ﹤0.01% |
72,300
-3,342
| -4% | -$3.46K |
|
3244
Zymeworks
ZYME
$1.73B
| $101K | ﹤0.01% |
15,858
-246,279
| -94% | -$1.82M |
|
|
DYNT
3245
DELISTED
Dynatronics Corp
DYNT
| $101K | ﹤0.01% |
134,718
-3,000
| -2% | -$2.3K |
|
3246
Dakota Gold
DC
$718M
| $100K | ﹤0.01% |
38,700
-49,400
| -56% | -$141K |
|
3247
Protara Therapeutics
TARA
$225M
| $100K | ﹤0.01% |
60,100
-23,500
| -28% | -$53.8K |
|
|
HARP
3248
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $100K | ﹤0.01% |
24,856
+3,496
| +16% | +$25.9K |
|
|
MTEM
3249
DELISTED
Molecular Templates, Inc.
MTEM
| $100K | ﹤0.01% |
15,758
-1,797
| -10% | -$14.3K |
|
|
ORLA
3250
DELISTED
Orla Mining
ORLA
| $99K | ﹤0.01% |
27,600
-27,100
| -50% | -$120K |
|
Similar funds
Renaissance Technologies's Q3 2023 Portfolio in Review
As of Q3 2023, Renaissance Technologies held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.34B in Q3 2023, closing 714 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in D.R. Horton worth $125M.
- Renaissance Technologies's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Renaissance Technologies added most to Netflix in Q3 2023, an estimated $385M increase.
- Renaissance Technologies's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Renaissance Technologies fully exited Chevron in Q3 2023, selling an estimated $185M.
- Renaissance Technologies's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Renaissance Technologies opened 464 new positions and closed 714 in Q3 2023.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.